ALLO vs BXP · rev $22.0K vs rev $3.48B
Allogene Therapeutics Inc (ALLO) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
ALLO currently screens at market cap $258.1M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the ALLO and BXP stock pages for the full models.
Not investment advice.